Stock & Company Details
Radnet Inc $RDNT
Price:
N/A
N/A
79M
$5.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-377.48
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
RDNT technical indicators
Latest Radnet Inc (RDNT) indicator readings as of 2026-10-09.
RDNT's 14-day RSI is 48.3, in neutral territory. At $70.91 it is trading 8.4% above its 200-day moving average of $65.40, and below its 50-day average of $73.17. Price sits in the middle of its Bollinger Bands ($66.16 to $78.01). ADX reads 15.4, indicating a range-bound market rather than a trend.
RDNT backtested strategy results
How 4 rule-based strategies performed on Radnet Inc (RDNT) over recent history, last backtested 2026-09-10. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +25.3% | 43% | 7 | -27.3% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +109.2% | 36% | 25 | -50.0% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +14.0% | 41% | 34 | -29.2% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +22.1% | 65% | 17 | -29.5% |
Overview
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
Finance Bot
Ask your questions
Start by typing a question below.
